Showing results (1421-1430 of 2,027) with videos related to
Sort By:
Pageof 203
The Journal of Urology|November 24, 2012
Pediatric genitourinary injuries in the United States from 2002 to 2010Gregory E Tasian, Herman S Bagga, Patrick B Fisher, et al.The Science of the Total Environment|November 24, 2019
Evaluation of a satellite-derived model parameterized by three soil moisture constraints to estimate terrestrial latent heat flux in the Heihe River basin of Northwest ChinaYunjun Yao, Yuhu Zhang, Qiang Liu, et al.Children and Youth Services Review|December 31, 2019
Child Maltreatment and Body Mass Index over Time: The Roles of Social Support and Stress ResponsesRebeccah L Sokol, Susan T Ennett, Nisha C Gottfredson, et al.Hepatology (Baltimore, Md.)|June 27, 2002
Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53Liang Qiao, Robert McKinstry, Seema Gupta, et al.The New England Journal of Medicine|June 3, 1993
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancerB Fisher, J Costantino, C Redmond, et al.American Journal of Clinical Oncology|November 6, 2018
An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?Sarah B Fisher, Yi-Ju Chiang, Barry W Feig, et al.Oncotarget|July 30, 2016
Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cellsSarmistha Talukdar, Swadesh K Das, Anjan K Pradhan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group StudyP Hoskins, E Eisenhauer, I Vergote, et al.Breast Cancer Research and Treatment|January 1, 1983
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapyB Fisher, C K Redmond, D L Wickerham, et al.Pageof 203